Fanglin Yu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 5
- Protein Interaction Studies and Fluorescence Analysis 2
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Xingguo Mei (21 shared papers)Zhiping Li (7 shared papers)Wei Gong (7 shared papers)Yang Yang (5 shared papers)Xiangyang Xie (8 shared papers)Zhiping Li (8 shared papers)Ying Li (4 shared papers)Xiangyang Xie (3 shared papers)
- Journals
- Current Drug Delivery (4 papers)Drug Delivery (3 papers)PLoS ONE (2 papers)Molecular Pharmaceutics (2 papers)Cancer Cell International (1 paper)
- Partner nations
- ChinaCzechiaUnited States
In The Last Decade
Fanglin Yu
34 papers receiving 698 citations
Peers
Comparison fields: 5 of 91
- Biomaterials 255
- Pharmaceutical Science 85
- Biochemistry 34
- Molecular Biology 313
- Food Science 71
Countries citing papers authored by Fanglin Yu
This map shows the geographic impact of Fanglin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanglin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanglin Yu more than expected).
Fields of papers citing papers by Fanglin Yu
This network shows the impact of papers produced by Fanglin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanglin Yu. The network helps show where Fanglin Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanglin Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 97 | |
| 2 | 2015 | 85 | |
| 3 | 2016 | 71 | |
| 4 | 2017 | 51 | |
| 5 | 2016 | 45 | |
| 6 | 2021 | 34 | |
| 7 | 2016 | 33 | |
| 8 | 2015 | 31 | |
| 9 | 2017 | 26 | |
| 10 | 2015 | 23 | |
| 11 | 2015 | 22 | |
| 12 | 2017 | 21 | |
| 13 | 2019 | 19 | |
| 14 | 2021 | 19 | |
| 15 | 2014 | 15 | |
| 16 | 2021 | 15 | |
| 17 | 2020 | 11 | |
| 18 | 2017 | 11 | |
| 19 | 2019 | 10 | |
| 20 | 2017 | 9 |
About Fanglin Yu
Fanglin Yu is a scholar working on Molecular Biology, Biomaterials, Pharmaceutical Science, Biomedical Engineering and Oncology, having authored 35 papers that have together received 708 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (6 papers), Advanced Drug Delivery Systems (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Nanoplatforms for cancer theranostics (5 papers), Drug Solubulity and Delivery Systems (2 papers), Pesticide Residue Analysis and Safety (2 papers) and Protein Interaction Studies and Fluorescence Analysis (2 papers). The work is most often cited by research in Biomaterials (255 citations), Pharmaceutical Science (85 citations), Biochemistry (34 citations), Molecular Biology (313 citations) and Food Science (71 citations). Fanglin Yu has collaborated with scholars based in China, Czechia and United States. Frequent co-authors include Xingguo Mei, Zhiping Li, Wei Gong, Yang Yang, Xiangyang Xie, Zhiping Li, Ying Li, Xiangyang Xie, Zhiyuan Wang and Yue Zhang. Their work appears in journals such as Current Drug Delivery, Drug Delivery, PLoS ONE, Molecular Pharmaceutics and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.